Recombinant human PRKAA2 + PRKAB2 + PRKAG1 protein (ab126911)
Key features and details
- Expression system: Baculovirus infected Sf9 cells
- Purity: > 70% Densitometry
- Active: Yes
- Tags: His tag C-Terminus
- Suitable for: SDS-PAGE, WB, Functional Studies
Description
-
Product name
Recombinant human PRKAA2 + PRKAB2 + PRKAG1 protein -
Purity
> 70 % Densitometry.
Purity was determined to be 70% by densitometry. Affinity purified. -
Expression system
Baculovirus infected Sf9 cells -
Protein length
Full length protein -
Animal free
No -
Nature
Recombinant -
-
Species
Human -
Tags
His tag C-Terminus
-
Associated products
-
Related Products
Specifications
Our Abpromise guarantee covers the use of ab126911 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
SDS-PAGE
Western blot
Functional Studies
-
Form
Liquid -
Additional notes
240-280 nmol/min/mg (lot specific).ab204881 (Acetyl Coenzyme A Carboxylase peptide) can be utilized as a substrate for assessing kinase activity
-
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
pH: 7.00
Preservative: 1.02% Imidazole
Constituents: 0.002% PMSF, 0.81% Sodium phosphate, 0.004% DTT, 25% Glycerol (glycerin, glycerine), 1.75% Sodium chlorideThis product is an active protein and may elicit a biological response in vivo, handle with caution.
General Info
-
Alternative names
- 5' AMP activated protein kinase catalytic subunit alpha 2
- 5' AMP activated protein kinase subunit beta 2
- 5' AMP activated protein kinase subunit gamma 1
see all
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab126911 has not yet been referenced specifically in any publications.